Amgen Inc. Canadian Depositary Receipt Logo

Amgen Inc. Canadian Depositary Receipt (AMGN)

NEO

Currency in CAD
32.10
-0.39 (-1.20%)

Closed

Aug 20, 2026

Day's Range

32.10
32.21

52 wk Range

20.46
32.49

Overview - AMGN - Amgen Inc. Canadian Depositary Receipt

Key Statistics

Valuation

Enterprise Value

361.57B

P/E (Trailing)

‪38.21‬

PEG Ratio

‪0.58‬

Price / Sales (TTM)

‪9.26‬

Price / Book

‪2.78‬

EV / EBITDA

‪21.39‬

Profitability

Gross Margin

‪72.04%‬

Profit Margin

‪17.38%‬

Operating Margin

‪28.72%‬

Return on Assets

‪7.03%‬

Return on Equity

‪105.67%‬

Ownership

Shares Outstanding

541.00M

Float

536.33M

Price stats

Beta

‪0.49‬

50-Day Avg

‪24.58‬

200-Day Avg

‪22.64‬

Dividends

Payout Ratio

‪0.00%‬

Frequency

Quarterly

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 19, 2025

Screened by Zoya using the AAOIFI methodology.

Peers - AMGN - Amgen Inc. Canadian Depositary Receipt

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on NEO.

Profile Summary - AMGN - Amgen Inc. Canadian Depositary Receipt

About

Amgen Inc. Canadian Depositary Receipt (CDR) is a financial instrument that provides Canadian investors with exposure to Amgen Inc., a leading biotechnology company focused on developing innovative human therapeutics. This CAD-hedged CDR represents fractional ownership of Amgen Inc. common stock through a dynamic CDR…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees28K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.